Futura Medical (GB:FUM) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Futura Medical plc has announced that its leading sexual health product, Eroxon®, will be available for pre-order online in the US starting September 2024, with in-store availability following in October. The company specializes in innovative and clinically proven sexual health products and is set to meet the significant demand in the erectile dysfunction market. Eroxon stands out as the only over-the-counter topical gel for erectile dysfunction, promising to help men achieve an erection within ten minutes.
For further insights into GB:FUM stock, check out TipRanks’ Stock Analysis page.